Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Diabetic neuroosteoarthropathy: the modern approaches for diagnosis and immobilization period determination (review)

Cover Page

Abstract


Diabetic neuroosteoarthropathy is complication of diabetes associated with high rates of amputations and mortality. The development of diagnostic methods may identify diabetic neuroosteoarthropathy at early X-ray negative stage before the development of radiographic changes. Treatment at this stage can prevent the development of progressive bone and joint deterioration. However, there is no unified approach to diagnose of X-ray negative stage. The timing of immobilization of the affected limb is still controversial among experts, and where is no objective methods for determining the completion of the acute stage of diabetic neuroosteoarthropathy. This review focuses on the current state of knowledge about the diagnosis, classification and criteria for completion of the active phase of diabetic neuroosteoarthropathy.

Y A Kaminarskaya

Endocrinology Research Centre, Moscow, Russian Federation

Email: osipovaulia@gmail.com ru

  1. Chisholm KA, Gilchrist JM. The Charcot joint: A modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13(1): 1-13. doi: 10.1097/CND.0b013e3181c6f55b.
  2. Slater RA, Ramot Y, Buchs A, et al. The diabetic Сharcot foot. Isr Med Assoc J. 2004;6(5):280-283.
  3. Pakarinen T-K, Laine H-J, Mäenpää H, et al. Long-term outcome and quality of life in patients with Сharcot foot. Foot Ankle Surg. 2009;15(4):187-191. doi: 10.1016/j.fas.2009.02.005.
  4. Sella EJ, Barrette C. Staging of Сharcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg. 1999;38(1):34-40. doi: 10.1016/s1067-2516(99)80086-6.
  5. Edmonds M, Petrova N, Edmonds A, et al. What happens to the initial bone marrow oedema in the natural history of Сharcot osteoarthropathy. Diabetologia. 2006;49(Suppl 1):684.
  6. Chantelau E, Richter A. The acute diabetic Сharcot foot managed on the basis of magnetic resonance imaging - a review of 71 cases. Swiss Med Wkly. 2013. doi: 10.4414/smw.2013.13831.
  7. Ruotolo V, Di Pietro B, Giurato L, et al. A new natural history of Сharcot foot. Clin Nucl Med. 2013;38(7):506-509. doi: 10.1097/RLU.0b013e318292eecb.
  8. Bolacchi F, Uccioli L, Masala S, et al. Proton magnetic resonance spectroscopy in the evaluation of patients with acute Сharcot neuro-osteoarthropathy. Eur Radiol. 2013;23(10): 2807-2813. doi: 10.1007/s00330-013-2894-y.
  9. Greenstein AS, Marzo-Ortega H, Emery P, et al. Magnetic resonance imaging as a predictor of progressive joint destruction in neuropathic joint disease. Arthritis Rheum. 2002;46(10):2814-2815. doi: 10.1002/art.10532.
  10. Valabhji J. Immunosuppression therapy posttransplantation can be associated with a different clinical phenotype for diabetic Сharcot foot neuroarthropathy. Diabetes Care. 2011;34(8):e135-e135. doi: 10.2337/dc11-0960.
  11. Kimmerle R, Chantelau E. Weight-bearing intensity produces Сharcot deformity in injured neuropathic feet in diabetes. Exp Clin Endocrinol Diabetes. 2007;115(6):360-364. doi: 10.1055/s-2007-970578.
  12. Sanders L, Frykberg R. Diabetic neuropathic osteoarthropathy: The Сharcot foot. In: Frykberg RG, editor. The high risk foot in diabetes mellitus. 1991. p.325-333.
  13. Rajbhandari SM, Jenkins RC, Davies C, et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45(8):1085-1096. doi: 10.1007/s00125-002-0885-7.
  14. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Сharcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999;29(12):736-746. doi: 10.2519/jospt.1999.29.12.736.
  15. Edmonds M, Watkins P. The Сharcot joint: Understanding its natural history leads to new treatment and prevention. Abstract. Diabet Med. 1984;1:144A.
  16. Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am. 1990;72(5):749-756.
  17. Rogers LC, Frykberg RG, Armstrong DG, et al. The Сharcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129. doi: 10.2337/dc11-0844.
  18. Petrova NL, Moniz C, Elias DA, et al. Is there a systemic inflammatory response in the acute Сharcot foot? Diabetes Care. 2007;30(4):997-998. doi: 10.2337/dc06-2168.
  19. Rogers LC, Bevilacqua NJ. Imaging of the Сharcot foot. Clin Podiatr Med Surg. 2008;25(2):263-274. doi: 10.1016/j.cpm.2008.01.002.
  20. Andersen LB, Dipreta J. Charcot of the calcaneus. Foot Ankle Clin. 2006;11(4):825-835. doi: 10.1016/j.fcl.2006.06.010.
  21. Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am. 2002;40(5):1171-1192. doi: 10.1016/s0033-8389(02)00036-2.
  22. Chantelau E, Poll L. Evaluation of the diabetic Сharcot foot by mr imaging or plain radiography - an observational study. Exp Clin Endocrinol Diabetes. 2006;114(8):428-431. doi: 10.1055/s-2006-924229.
  23. Loredo R, Rahal A, Garcia G, et al. Imaging of the diabetic foot diagnostic dilemmas. Foot & Ankle Specialist. 2010;3(5): 249-264. doi: 10.1177/1938640010383154.
  24. Sartoris DJ. Cross-sectional imaging of the diabetic foot. J Foot Ankle Surg. 1994;33(6):531-545.
  25. Edmonds ME, Edmonds A, Elias D, et al. CT scans reveal the full extent of bone and joint damage of the Charcot foot. Abstract. Diabet Med. 2010;27 (Suppl 1):18.
  26. Keenan AM. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989;149(10):2262. doi: 10.1001/archinte.1989.00390100078019.
  27. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. Am J Roentgenol. 1992;158(1):9-18. doi: 10.2214/ajr.158.1.1727365.
  28. Tomas MB, Patel M, Marwin SE, et al. The diabetic foot. Br J Radiol. 2000;73(868):443-450. doi: 10.1259/bjr.73.868.10844873.
  29. Basu S, Zhuang H, Alavi A. Imaging of lower extremity artery atherosclerosis in diabetic foot. Clin Nucl Med. 2007;32(7): 567-568. doi: 10.1097/RLU.0b013e3180646ac0.
  30. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Сharcot neuroarthropathy in diabetic patients: Comparison of ring pet, hybrid pet, and magnetic resonance imaging. Foot Ankle Int. 2004;25(12):890-895.
  31. Pickwell KM, Van Kroonenburgh MJ, Weijers RE, et al. F-18 fdg pet/ct scanning in Сharcot disease. Clin Nucl Med. 2011;36(1):8-10. doi: 10.1097/RLU.0b013e3181feeb30.
  32. Tins BJ, Cassar-Pullicino VN. Non-infective inflammatory bone marrow disease. In: Baur-Melnyk A, editor. Magnetic resonance imaging of the bone marrow. Springer; 2012. p. 311-335.
  33. Krüger K, Heindel W, Burger C, et al., editors. Mr-tomographische darstellung der unkomplizierten, sekundären frakturheilung am beispiel der distalen radiusfraktur. RÖFO. Fortschritte auf dem Gebiete der Röntgenstrahlen und der neuen bildgebenden Verfahren; 1999: Thieme.
  34. Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012;8(3):133-143. doi: 10.1038/nrrheum.2012.1.
  35. Ledermann HP, Morrison WB. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: Mr imaging. Semin Musculoskelet Radiol. 2005;09(03):272-283. doi: 10.1055/s-2005-921945.
  36. Marcus CD, Ladam-Marcus VJ, Leone J, et al. Mr imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics. Radiographics. 1996;16(6):1337-1348. doi: 10.1148/radiographics.16.6.8946539.
  37. Zampa V, Bargellini I, Rizzo L, et al. Role of dynamic mri in the follow-up of acute Сharcot foot in patients with diabetes mellitus. Skeletal Radiol. 2011;40(8):991-999. doi: 10.1007/s00256-010-1092-0.
  38. Vanhoenacker FM, Eyselbergs M, Demeyere A. Bone marrow changes in acute and chronic trauma. In: Baur-Melnyk A, editor. Magnetic resonance imaging of the bone marrow. Springer; 2012. p. 265-292.
  39. Schmid MR, Hodler J, Vienne P, et al. Bone marrow abnormalities of foot and ankle: Stir versus t1-weighted contrast-enhanced fat-suppressed spin-echo mr imaging. Radiology. 2002;224(2):463-469. doi: 10.1148/radiol.2242011252.
  40. Chantelau EA, Grutzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014;144:w13948. doi: 10.4414/smw.2014.13948.
  41. Gazis A, Pound N, Macfarlane R, et al. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004;21(11):1243-1246. doi: 10.1111/j.1464-5491.2004.01215.x.
  42. Osterhoff G, Boni T, Berli M. Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment. Foot Ankle Int. 2013;34(3):359-364. doi: 10.1177/1071100712464957.
  43. Демина А.Г., Бреговский В.Б., Карпова И.А. Критерии продолжительности иммобилизации пораженной конечности при диабетической нейроостеоартропатии Шарко. // Сахарный диабет. - 2014. - Т. 17. - №4 - С.60-65. [Demina AG, Bregovskiy VB, Karpova IA. Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy. Diabetes mellitus. 2014; 17(4):60-65. (In Russ).] doi: 10.14341/dm2014460-65.
  44. Goodridge D, Trepman E, Sloan J, et al. Quality of life of adults with unhealed and healed diabetic foot ulcers. Foot Ankle Int. 2006;27(4):274-280.
  45. Nabuurs-Franssen MH, Huijberts MSP, Nieuwenhuijzen Kruseman AC, et al. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. 2005;48(9):1906-1910. doi: 10.1007/s00125-005-1856-6.
  46. Pinzur MS, Evans A. Health-related quality of life in patients with Charcot foot. Am J Orthop (Belle Mead NJ). 2003;32(10):492-496.
  47. Willrich A, Pinzur M, McNeil M, et al. Health related quality of life, cognitive function, and depression in diabetic patients with foot ulcer or amputation. A preliminary study. Foot Ankle Int. 2005;26(2):128-134.
  48. Van Adrichem RA, Debeij J, Nelissen RGHH, et al. Below-knee cast immobilization and the risk of venous thrombosis: Results from a large population-based case-control study. J Thromb Haemost. 2014;12(9):1461-1469. doi: 10.1111/jth.12655.
  49. Moura-Neto A, Fernandes TD, Zantut-Wittmann DE, et al. Charcot foot: Skin temperature as a good clinical parameter for predicting disease outcome. Diabetes Res Clin Pract. 2012;96(2):e11-e14. doi: 10.1016/j.diabres.2011.12.029.
  50. McCrory JL, Morag E, Norkitis AJ, et al. Healing of Charcot fractures: Skin temperature and radiographic correlates. The Foot.1998;8(3):158-165. doi: 10.1016/s0958-2592(98)90052-9.
  51. McGill M, Molyneaux L, Bolton T, et al. Response of charcot's arthropathy to contact casting: Assessment by quantitative techniques. Diabetologia. 2000;43(4):481-484. doi: 10.1007/s001250051332.

Views

Abstract - 1044

PDF (Russian) - 1056


Copyright (c) 2015 Каминарская Ю.А.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.